CEAD WNY Team
Dr. Kinga Szigeti
Dr. Szigeti is a board certified neurologist with subspecialty training in genetics and cognitive disorders. She is the founding director of the Alzheimer Disease and Memory Disorders Center (ADMDC) at the University at Buffalo. The ADMDC was founded in 2010 to provide state of the art medical services consistent with evolving practice standards which enhances and standardizes AD/D care in the region. The ADMDC's emphasis on early diagnosis and treatment is consistent with the public health mandate, as it translates into better outcomes and delayed institutionalization.
Co-Director of the CEAD
At the ADMDC our mission is to provide compassionate, state of the art care for patients and families affected by Alzheimer disease and other cognitive disorders. We have a multidisciplinary approach with a team of professionals caring for the patients and families. The team includes neurologists, neuropsychologists, psychiatrists, neuroimagers, social workers and nursing to address all the needs of the patients and caregivers.
When it comes to Alzheimer's disease and dementia, a drug that can completely stop or prevent the disease is the greatest hope of patients, family members and health care providers. This is what our patients at the UB Alzheimer's Disease and Memory Disorders Center tell us repeatedly and what patients all over the globe are wishing for. Current therapies do help slow the progress of Alzheimer's disease, but finding the cure is a huge endeavor requiring collaboration between patients, caregivers, doctors, universities, pharmaceutical companies and funding agencies.
As part of the Jacobs School of Medicine and Biomedical Sciences and UBMD Neurology, the UB Alzheimer's Disease and Memory Disorders Center is able to confront this critical public health issue not only by treating patients but by researching new discoveries that will lead us closer to a cure for Alzheimer's and dementia. The ADMDC facilitates patient participation in clinical trials for promising new Alzheimer's drugs.
The ADMDC incorporates an active translational research program housed in the UB Clinical and Translational Research center and is affiliated with the prestigious Clinical and Translational Research Award. Dr. Szigeti has had external funding from the Alzheimer's Association and from the National Institute of Aging of the National Institutes of Health over the years. Her work focuses on the genetics of Alzheimer's disease, a very heterogeneous disorder with a strong genetic component. Analysis of the genetic background will enable better classification of disease subgroups that should then lead to new and more effective medications to either delay disease onset or prolong the earlier stage of the disease when symptoms are very mild and patients still function relatively well.
Dr. Bruce Troen
Co-Director of the CEAD
Dr. Bruce Troen is Professor and Chief of the Division of Geriatrics and Palliative Medicine within the Department of Medicine at the University at Buffalo. He is board certified in Internal Medicine and in Geriatrics. In addition to being the Co-Director of the Center of Excellence in Alzheimer’s Disease, Dr. Troen is also the Director of the Institute for Person Centered Care at the University at Buffalo. He is also a physician-investigator with the Veterans Affairs Healthcare System and is presently on staff at the Buffalo VA Western New York Healthcare System. Dr. Troen has served on the faculty of the University of Michigan, Mount Sinai School of Medicine, and the University of Miami where he was the interim Chief of the Division of Geriatric Medicine and Gerontology.
Dr. Troen is a physician-scientist-educator formally trained in geriatrics and molecular biology with major foci in osteoporosis, longevity/aging mechanisms, and frailty, all of which result in great morbidity in the elderly. He is also very interested in the impact of vitamin D supplementation in humans, which may be only one component of critical nutritional aspects that can modulate healthy aging. Dr. Troen has an active basic and translational scientific research program, which has garnered support from the National Institutes of Health, Veterans Affairs, and private foundations. In addition, and very importantly, Dr. Troen has over 25 years experience as a front line geriatrician caring for the elderly and for individuals with dementia. He is dedicated to interdisciplinary team-based holistic person centered care, which is particularly needed for individuals and families with dementia.
Dr. Troen is active educationally in the clinical setting, giving frequent lectures both locally and nationally, and developing, participating in and leading symposia at national meetings. He has also successfully worked in multiple collaborative settings including as the Chair and Vice-Chair of the Program Committee for the annual scientific meeting of the American Geriatrics Society.
As both a clinician and an academic geriatrician scholar, Dr. Troen seeks to enhance the quality of life of dementia patients and their families by providing clinical services, support and training to patients, family members, caregivers, and health care providers. The demographics of a rapidly growing aging population, the corresponding increase of at-risk frail and chronically ill elders, and the burgeoning clinical and research interest in dementia, frailty and healthspan make this a propitious time to build and strengthen clinical services and scholarship. Developing a vertically integrated, horizontally connected, and coordinated interdisciplinary continuum of care for an aging population can best accomplish this. The goals and activities of the Center of Excellence for Alzheimer’s Disease aligned with the mission of increasing recognition and screening for cognitive impairment and dementia, and in providing a pathway for patients and caregivers to receive the best possible primary and referral care.
As a Co-Investigator and Nurse Practitioner for the CEAD WNY , she is responsible for providing clinical leadership for educational outreach to Primary Care Providers and students in the healthcare professions assisting them to provide current evidenced based practices for